The COMBO randomised control trial, which compared the effectiveness of SCS with multiple modalities to conventional SCS in patients with chronic pain, found 88% of patients were responders with multiple modalities, which is defined as patients achieving 50% or greater pain relief compared to baseline. The combination of different therapy features that promote simplicity like the WaveWriter Alpha SCS Systems enable enhanced personalisation in the advanced treatment of chronic pain." Jan Vesper, Department of Functional Neurosurgery and Stereotaxy at the University Hospital of Düsseldorf, said: "Being able to offer my patients different therapy options is important because it provides them with pain relief that can maintain long-term results. The systems feature combination therapy, a portfolio that has the ability to layer paraesthesia and paraesthesia-free options simultaneously and support up to 32 contacts that target specific nerves along the spinal cord to meet the personal pain relief coverage needs of the individual patient. The Bluetooth platform enables faster programming that can be done while maintaining a typical physical distance of 10 feet between the programmer and the patient. It is also indicated for peripheral nerve stimulation of the trunk for pain management. The WaveWriter Alpha SCS Systems received CE mark and are indicated as an aid in the management of chronic intractable pain. SCS therapies provide pain relief by delivering pulses of mild electric current to the spinal cord to interrupt pain signals traveling to the brain. The portfolio, consisting of four MRI conditional, Bluetooth-enabled implantable pulse generators (IPGs), offers rechargeable and non-rechargeable options, and access to waveforms that can cover multiple areas of pain.Ĭhronic pain impacts approximately 100 million people across Europe.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |